Burning Rock Biotech Limited
BNR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $515,822 | $537,435 | $563,238 | $507,862 |
| % Growth | -4% | -4.6% | 10.9% | – |
| Cost of Goods Sold | $153,422 | $174,208 | $183,199 | $143,716 |
| Gross Profit | $362,400 | $363,227 | $380,039 | $364,146 |
| % Margin | 70.3% | 67.6% | 67.5% | 71.7% |
| R&D Expenses | $232,290 | $347,016 | $421,868 | $367,858 |
| G&A Expenses | $261,638 | $437,821 | $568,284 | $490,256 |
| SG&A Expenses | $452,542 | $685,532 | $938,578 | $793,352 |
| Sales & Mktg Exp. | $190,904 | $247,711 | $370,294 | $303,096 |
| Other Operating Expenses | $35,127 | $0 | $0 | $0 |
| Operating Expenses | $719,959 | $1,032,548 | $1,360,446 | $1,161,210 |
| Operating Income | -$357,559 | -$669,321 | -$980,407 | -$797,064 |
| % Margin | -69.3% | -124.5% | -174.1% | -156.9% |
| Other Income/Exp. Net | $16,818 | $18,020 | $11,159 | $1,266 |
| Pre-Tax Income | -$340,741 | -$651,301 | -$969,248 | -$795,798 |
| Tax Expense | $5,885 | $2,388 | $1,985 | $899 |
| Net Income | -$346,626 | -$653,689 | -$971,233 | -$796,697 |
| % Margin | -67.2% | -121.6% | -172.4% | -156.9% |
| EPS | -33.67 | -63.84 | -93.47 | -76.45 |
| % Growth | 47.3% | 31.7% | -22.3% | – |
| EPS Diluted | -33.67 | -63.84 | -93.47 | -76.45 |
| Weighted Avg Shares Out | 10,294 | 10,240 | 10,391 | 10,421 |
| Weighted Avg Shares Out Dil | 10,294 | 10,240 | 10,391 | 10,421 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12,212 | $17,956 | $9,458 | $3,457 |
| Interest Expense | $0 | $0 | $0 | $1,536 |
| Depreciation & Amortization | $52,200 | $133,400 | $124,096 | $47,766 |
| EBITDA | -$270,232 | -$517,901 | -$856,311 | -$746,496 |
| % Margin | -52.4% | -96.4% | -152% | -147% |